Sarofim Equity
Prospectus
Document/cda16a1d05675ddf94540af28fdd0a63.msdoc?key=707fd4b5bf3d6080991524c71111c36059364ddf623af3d9
#
|
Annual Report
Document/c15c22e4ccc3f4abad460fde9c831500.msdoc?key=707fd4b5bf3d6080991524c71111c36059364ddf623af3d9
#
|
Semi-Annual Report
Document/a10c6e552b38f056eee80bfa203eed60.msdoc?key=707fd4b5bf3d6080991524c71111c36059364ddf623af3d9
#
|
SAI
Document/2a8c1b795d7d138463212495f46b3ea4.msdoc?key=707fd4b5bf3d6080991524c71111c36059364ddf623af3d9
#
|
XBRL Interactive Data
Document/74787154bee26e4fdd84ef63eddd03d9.msdoc?key=707fd4b5bf3d6080991524c71111c36059364ddf623af3d9
#
|
Supplement to SAI
[1/4/2024]
(HTM)
Document/62b5d27f8732ba2c5daf58ef9627f4a6.msdoc?key=707fd4b5bf3d6080991524c71111c36059364ddf623af3d9
#
Supplement to SAI
[7/10/2023]
(HTM)
Document/7da9e38b599345e40896769d0cd71af8.msdoc?key=707fd4b5bf3d6080991524c71111c36059364ddf623af3d9
#
Supplement to SAI
[7/3/2023]
(HTM)
Document/2f87893d32e9b9258cabd132a74876d9.msdoc?key=707fd4b5bf3d6080991524c71111c36059364ddf623af3d9
#
Back To TOC: Prospectus
Back To TOC: SAI